Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulator | Patent Number 10208073

US 10208073 B2
Application Number15874325
Publication NumberUS 20180194788 A1
Pendency1 year, 1 month, 2 days
Filled DateJan 18, 2018
Priority DateNov 29, 2011
Publication DateJul 12, 2018
Expiration DateNov 28, 2031
Inventor/ApplicantsClaudio Giuliano
Peter Manini
Roberta Cannella
Valentino J Stella
Alessio Venturini
Claudio Pietra
Valentino J. Stella
Emanuela Lovati
Luca Fadini
ExaminesWILLIS, DOUGLAS M
Art Unit1624
Technology Center1600
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.